Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men - PubMed (original) (raw)
Clinical Trial
Survey of C-reactive protein and cardiovascular risk factors in apparently healthy men
L E Rohde et al. Am J Cardiol. 1999.
Abstract
Several prospective studies have demonstrated a direct association between C-reactive protein (CRP) levels and the risks of developing cardiovascular disease. Few studies, however, have explored the interrelations between CRP levels and other risk factors for cardiovascular disease. We evaluated the relation of CRP with several cardiovascular risk factors in a cross-sectional survey of 1,172 apparently healthy men. There were significant positive associations between CRP levels and age, number of cigarettes smoked per day, body mass index, systolic and diastolic blood pressure, total cholesterol, triglycerides, lipoprotein(a), apolipoprotein B, tissue-type plasminogen activator antigen, D-dimers, total homocysteine, and fibrinogen (all p values <0.05). Significant inverse associations were observed for exercise frequency, high-density lipoprotein cholesterol, and apolipoprotein A-I and A-II (all p values <0.02). In multivariate analysis, age, smoking status, and serum levels of tissue-type plasminogen activator antigen, fibrinogen, lipoprotein(a), and total homocysteine were independent correlates of CRP levels. Finally, in an analysis controlled either for all the independent correlates or for several usual risk factors, we observed progressive increases in levels of CRP with increasing prevalence of risk factors (p for trend <0.001 for independent correlates and <0.01 for usual risk factors). In conclusion, in a large cohort of apparently healthy men, CRP levels were associated with several cardiovascular risk factors. These data are compatible with the hypothesis that CRP levels may be a marker for preclinical cardiovascular disease.
Similar articles
- Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women.
Mora S, Lee IM, Buring JE, Ridker PM. Mora S, et al. JAMA. 2006 Mar 22;295(12):1412-9. doi: 10.1001/jama.295.12.1412. JAMA. 2006. PMID: 16551713 - The relationship between C-reactive protein and other cardiovascular risk factors in men and women.
Arena R, Arrowood JA, Fei DY, Helm S, Kraft KA. Arena R, et al. J Cardiopulm Rehabil. 2006 Sep-Oct;26(5):323-7; quiz 328-9. doi: 10.1097/00008483-200609000-00009. J Cardiopulm Rehabil. 2006. PMID: 17003600 - C-reactive protein and coronary heart disease in western Turkey.
Onat A, Sansoy V, Yildirim B, Keleş I, Uysal O, Hergenç G. Onat A, et al. Am J Cardiol. 2001 Sep 15;88(6):601-7. doi: 10.1016/s0002-9149(01)01799-4. Am J Cardiol. 2001. PMID: 11564380 - C-reactive protein and cardiovascular disease: a review of risk prediction and interventions.
de Ferranti S, Rifai N. de Ferranti S, et al. Clin Chim Acta. 2002 Mar;317(1-2):1-15. doi: 10.1016/s0009-8981(01)00797-5. Clin Chim Acta. 2002. PMID: 11814453 Review. - Using C-reactive protein to assess cardiovascular disease risk.
Shishehbor MH, Bhatt DL, Topol EJ. Shishehbor MH, et al. Cleve Clin J Med. 2003 Jul;70(7):634-40. doi: 10.3949/ccjm.70.7.634. Cleve Clin J Med. 2003. PMID: 12882386 Review.
Cited by
- Elevation of C-reactive protein in people with prehypertension.
King DE, Egan BM, Mainous AG 3rd, Geesey ME. King DE, et al. J Clin Hypertens (Greenwich). 2004 Oct;6(10):562-8. doi: 10.1111/j.1524-6175.2004.03577.x. J Clin Hypertens (Greenwich). 2004. PMID: 15470285 Free PMC article. - Relations of plasma high-sensitivity C-reactive protein to various cardiovascular risk factors.
Ryu SY, Lee YS, Park J, Kang MG, Kim KS. Ryu SY, et al. J Korean Med Sci. 2005 Jun;20(3):379-83. doi: 10.3346/jkms.2005.20.3.379. J Korean Med Sci. 2005. PMID: 15953856 Free PMC article. - Exercise, vascular wall and cardiovascular diseases: an update (Part 1).
Leung FP, Yung LM, Laher I, Yao X, Chen ZY, Huang Y. Leung FP, et al. Sports Med. 2008;38(12):1009-24. doi: 10.2165/00007256-200838120-00005. Sports Med. 2008. PMID: 19026018 Review. - Lipoprotein(a)-The Crossroads of Atherosclerosis, Atherothrombosis and Inflammation.
Ugovšek S, Šebeštjen M. Ugovšek S, et al. Biomolecules. 2021 Dec 24;12(1):26. doi: 10.3390/biom12010026. Biomolecules. 2021. PMID: 35053174 Free PMC article. Review. - Dose-response impact of various tocotrienols on serum lipid parameters in 5-week-old female chickens.
Yu SG, Thomas AM, Gapor A, Tan B, Qureshi N, Qureshi AA. Yu SG, et al. Lipids. 2006 May;41(5):453-61. doi: 10.1007/s11745-006-5119-1. Lipids. 2006. PMID: 16933790
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous